Metabolic dysfunction-associated steatohepatitis (MASH) is a liver condition where fat builds up in the liver, causing inflammation and damage. Unlike liver issues caused by alcohol, MASH is linked to problems like obesity, diabetes, and high cholesterol. If left untreated, MASH can…
Resmetirom: una nueva y prometedora frontera en la terapia MASH
Fatty liver, an increasing global health concern Metabolic dysfunction-associated steatotic liver disease (MASLD), commonly referred to as fatty liver disease, is becoming a global health concern, with over 30% of adults affected. In regions like South America and the Middle East,…
La lucha oculta: cómo la fibrosis está redefiniendo el futuro del tratamiento de la MASH (esteatohepatitis asociada a disfunción metabólica)
Imagine your body as a bustling city where everything works seamlessly, maintaining the delicate balance of health. Now, think of non-alcoholic steatohepatitis (NASH) or Metabolic dysfunction-associated steatohepatitis (MASH) as an insidious construction project gone wrong inside this city, gradually laying down…
Diabetes Researchers Find Switch for Fatty Liver Disease
Duke researchers have identified a key fork in the road for the way the liver metabolism deals with carbohydrates, fats, and protein. They say it could be a promising new target for combating the pandemics of fatty liver disease and prediabetes….